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Background: High altitude pulmonary edema (HAPE) affects individuals and is characterized by alveolar flooding
with protein-rich edema as a consequence of blood-gas barrier disruption. In this study, we hypothesized that
aquaporin 5 (AQP5) which is one kind of water channels may play a role in preservation of alveolar epithelial barrier
integrity in high altitude pulmonary edema (HAPE).
Methods: Therefore, we established a model in Wildtype mice and AQP5 −/− mice were assingned to normoxic
rest (NR), hypoxic rest (HR) and hypoxic exercise (HE) group. Mice were produced by training to walk at treadmill
for exercising and chamber pressure was reduced to simulate climbing an altitude of 5000 m for 48 hours. Studies
using BAL in HAPE mice to demonstrated that edema is caused leakage of albumin proteins and red cells across
the alveolarcapillary barrier in the absence of any evidence of inflammation.
Results: In this study, the Lung wet/dry weight ratio and broncholalveolar lavage protein concentrations were
slightly increased in HE AQP5 −/− mice compared to wildtype mice. And histologic evidence of hemorrhagic
pulmonary edema was distinctly shown in HE group. The lung Evan’s blue permeability of HE group was showed
slightly increased compare to the wildtype groups, and HR group was showed a medium situation from normal to
HAPE development compared with NR and HE group.
Conclusions: Deletion of AQP5 slightly increased lung edema and lung injury compared to wildtype mice during
HAPE development, which suggested that the AQP5 plays an important role in HAPE formation induced by high
altitude simulation.
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High-altitude pulmonary edema (HAPE) is an acute po-
tentially fatal disease that occurs as a result of a rapid
exposure to high altitude (3000 m above sea level) [1-3].
Due to exposed to altitudes higher than 3,000 m above
sea level, the HAPE morbidity rate ranges from 0.4 to 2
[4,5]. Previous studies have shown that HAPE has
family-specific, race-specific and individual susceptibility
tendencies [6]. After arrived in high altitude, the amount
of alveolar fluid depends on its’ dynamic balance between
escaping liquid from the pulmonary vasculature and the
reabsorption by the alveolar respiratory epithelium [7]. It
is believed that high lung water permeability facilitates
fluid formation and resolution of pulmonary edema [8].* Correspondence: bai.chunxue@zs-hospital.sh.cn
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reproduction in any medium, provided the orTherefore, ideal HAPE treatment should protect the in-
tegrity of alveolar-capillary membrane and increase the
alveolar fluid reabsorption. Unfortunately, the HAPE is
a noncardiogenic, hydrostatic lung edema which has
been characterized as a non-inflammatory high perme-
ability type leak caused by stress failure [9-11]. To date,
about HAPE pathogenesis is not fully understood. Pre-
vious evidence suggested that uneven hypoxic pulmo-
nary vasoconstriction, pulmonary capillary damage and
increased pulmonary artery pressure play important
roles in HAPE pathogenesis [12,13]. The endothelial
barrier has been commonly believed as the initial mecha-
nism triggering the development of HAPE [14]. In addition,
some previous results showed that endothelial and epithe-
lial stress failure were contribute to HAPE development
in a rat model of HAPE morphological studies [15]. So
far, there are many difficulties during effective treatments. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
She et al. Diagnostic Pathology 2013, 8:193 Page 2 of 7
http://www.diagnosticpathology.org/content/8/1/193against HAPE, such as alveolar epithelium swelling and
epithelium barrier disruption. So the epithelium and the
epithelium barrier become the new target of the study in
the maintenance of alveolar-capillary integrity and normal
alveolar function during HAPE development. The aqua-
porins (AQP) are a family of membrane water channels,
which facilitate water transport across cell membranes in
response to osmotic gradients [11-13] and involved in
physiological functions including water/salt homeostasis,
epidermal hydration and exocrine fluid secretion [16].
Aquaporin 5 (AQP5) is one of the members of AQP
which is expressed at apical membrane of alveolar type I
cell in the lungs [17]. Some studies were shown that
AQP5 facilitates the principal route for osmotically
driven water transport between alveolar epithelium and
capillary compartments [17,18]. In the airways, though
AQP3 and AQP4 facilitate osmotic water transport also,
their deletion does not impair fluid absorption [19,20]. In
contrast to these, AQP5 deletion significantly reduced
alveolar-capillary osmotic water permeability up to 15
fold in mice [17]. And high pulmonary vascular pres-
sures when expose to hypoxia result in transient break-
down of the integrity of the alveolar-capillary barrier,
permitting fluid accumulation [21,22]. Therefore, we pos-
tulated that AQP5 may be beneficial in hydrostatic lung
edema. We hypothesized that AQP5 may play an im-
portant role in alveolar epithelial barrier function in for-
mation of lung edema involve fluid transport for HAPE.
In this study, we aimed to test whether AQP5 facilitate
the integrity of alveolar epithelia barrier and beneficiate
for the integrity of alveolar-capillary barrier, using our




The AQP5 −/− knockout and wild type adult male
mice (weight 18–23 g) were generously provided by
Dr. Alan S. Verkman (University of California, San
Francisco) and maintained at the Fudan University ani-
mal facility. The protocol was approved by the Animal
Care Committees of Fudan University. All animals
were conducted in accordance with the Guidelines for
the Use and Care of Research Animals published by the
National Institutes of Health.
Hypoxia exposure procedure
Nine AQP5 −/− knockout mice participated in this study
and were randomly assigned as the NR group (mice ex-
posed to normobaric normoxia at rest), HR group (mice
exposed to hypobaric hypoxia at rest) and HE group
(mice exposed to hypobaric hypoxia with exercise). In
addition, nine wildtype mice were seen as a control in
the same grouping method. The research protocol wasperformed as described previously [15]. Briefly, mice
were trained for exercising in treadmill and the chamber
pressure was gradually reduced (20 m/sec) to reach a
simulate altitude of 5000 m above sea level. The tread-
mill walking speed was setup to a exercise intensity of
6 m/min. Mice of NR group had never been exposed to
normobaric normoxia caused by an independently con-
trolled antechamber used in the hypobaric hypoxic
procedures. Hypoxia exposure procedure took about
20–30 minutes interval and animals supplied fresh
food and water every 4 hours regularly. All data was
collected at a safety simulated altitude of 3800 m
above sea level [23].
Bronchoalveolar lavage (BAL)
Bronchoalveolar lavage (BAL) was selectively performed
with the left hemi-lung. The lungs were injected with
0.5 ml 0.9% saline, and then gently retrieved into sterile
containers [21] after 2–3 times gentle flushing. The red
and white blood cell counts were performed on Sysmex
KX-21 (Sysmex Co., Ltd, Kobe, Japan). Total protein and
albumin were measured using acid titration and im-
munoturbidimetry by Automatic Analyzer (HITACHI-
7600, Hitachi, Ltd, Lbaraki Japan) respectively [15].
Lung wet-to-dry weight ratio (W/D)
The trachea were inserted into the mice after tracheotomy
in a supine position. The lungs were isolated after chest
opening, and the right superior lobe of hemi-lung was ex-
sanguinated and excised. After wet weights were mea-
sured on electronic scale (HANGPING FA1104, Shanghai
Precision & Scientific Instrument Co., Ltd, China), the
lungs were dried in an oven (Shanghai Yuejin Medical
Instruments Factory, China) at 56°C for 72 hours in order
to get the dry weights. Lung wet-to-dry weight ratio was
calculated as described previously [15,24,25].
Lung histology
The rest of right middle lobe lung was immersed in forma-
lin, embedded in paraffin, sectioned and stained with
hematoxylin and eosin for histological studies. The severity
of lung injury was inspected by light microscopy (Nikon
Eclipse 50i, Nikon Instruments Inc., Tokyo, Japan) [25].
Alveolar-capillary permeability
The alveolar-capillary permeability was performed with
Evans Blue dye (EBD) method [24,26]. Briefly, One
third of each group were performed the intravenous in-
jection of EBD (30 mg/kg) for an estimate of alveolar-
capillary membrane leakage through the caudal vein
which avoiding the influence on conventional results
in this study [27]. The lung was separated and incu-
bated at 37°C for 24 h and centrifuged at 5,000 × g for
30 min. The optical density of the supernatant was
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spectrophotometry at 620 nm. The concentration of
EBD was determined from a standard curve of EBD
formamide solutions.
Statistical analyses
The data were displayed as mean and Standard Error Of
Mean (SEM) unless otherwise specified using SAS 6.12 soft-
ware (SAS Institute Inc., North Carolina, USA). In addition,
multiple groups compared were performed by one-way
analysis of variance (ANOVA) procedures with Bonferroni
test [28]. As well, when the statistical significance was
reached (alpha level of p ≤0.05) where significant mean
differences occurred.
Results
Five out of nine mice exposed to hypoxia with exercise
died in the 48 hours experiment (three AQP5 −/− mice
and two wildtype mice). All animals in the other experi-
ment groups survived (Figure 1).
Lung wet-to-dry ratio
The wet-to-dry lung weight ratio was measured to eva-
luated fluid accumulation in the lung specimens [29].Figure 1 Survival curve. There were no significant differences between A
and AQP5 −/−, B: HE wildtype vs control wildtype, C: HE AQP5 −/− vs c
blue dotted line; Control AQP5 −/−, red dotted line; HE wildtype, blue full liCompared with the NR groups, the W/D of AQP5 −/−
and wildtype mice in the HE groups mice were signifi-
cantly increased (p < 0.01). In the HR group, the W/D of
AQP5 −/− is higher than the NR group (p < 0.05). How-
ever, there was no significant difference in the lung W/D
ratio between the HE and HR groups between AQP5 −/−
mice and wildtype mice (Figure 2).
BAL
BAL protein is an indicator of lung alveolar-capillary mem-
brane permeability changes [30]. The total protein of HE
group both AQP5 −/− mice and wildtype mice were all in-
creased compared with the NR group (p < 0.05) (Figure 3A).
In addition, the albumin in the HE group has the same
results accompany with the total protein, which is
higher than the NR group, especially in AQP5 −/− mice
(p < 0.01) (Figure 3B). However, there was no significant
difference between the AQP5 −/− and the wildtype mice
of total protein and albumin in the HE group (p > 0.05)
(Figure 3A, B). At the same time, the alveolar red blood
cell counts in AQP5 −/− mice and wildtype mice were
all increased in the HE group compared with the NR
group (p < 0.05, respectively) in BAL (Figure 3C). How-
ever, there was no significant difference between theQP5 −/− and wildtype p > 0.05. A: HE vs control between wildtype
ontrol AQP5 −/−, D: HE AQP5 −/− vs HE wildtype. Control wildtype,
ne; HE AQP5 −/−, red full line.
Figure 2 Lung wet-to-dry weight ratio. **p < 0.01 for the HE
groups between AQP5 −/− and wildtype vs. controls; *p < 0.05 for
the HR AQP5 −/− vs. the control. n = 6 in each group. Values are
given as the mean ± SEM.
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and NR group (p > 0.05) (Figure 3C).
Lung edema and morphology
Using light microscopy, we investigated the details of
lung morphology in the study. Compared with the NRFigure 3 Protein content and cell counts in BAL. (A) Total protein. *p <
(B) Albumin. **p < 0.01 for the HE AQP5 −/− group vs. controls. *p < 0.05 fo
given as the mean ± SEM. (C) Red blood cell counts. * p < 0.05 for the HE
cell counts. There were no significant differences within these groups. n = 3groups, lung slices form the HE group displayed markedly
alveolar oedema, thickening of pulmonary interstitium
swollen and red blood cells in the alveolar space (Figure 4).
However, there was no significant different between the
AQP5 −/− mice and wildtype mice in HE group. In
addition, the AQP5 −/− mice in the HR group displayed
significantly thickened alveolar septum and few red blood
cells in alveolar space, but no obvious alveolar edema than
the wildtype mice in the HR group, which suggested that
hypoxia per se does not induce HAPE (Figure 4).
Alveolar-capillary permeability
Evan’s blue method was performed to inspect the
alveolar-capillary permeability by the extravasation
leaked into the lung parenchyma [31]. Compared with
the NR and HR group, the EBD of HE group was in-
creased obviously both in the AQP5 −/− mice and wild-
type mice (p < 0.01, Figure 5). Similarly, EBD in lungs
of AQP5 −/− and HR wildtype mice in HR group was
significantly higher than NR group respectively (p < 0.01,
p < 0.05,). Moreover, in the HE and HR groups, the lung
Evan’s blue leakage of AQP5 −/− mice was slightly0.05 for the HE groups between AQP5 −/− and wildtype vs. controls.
r the HE wildtype group vs. controls. n = 6 in each group. Values are
groups between AQP5 −/− and wildtype vs. controls. (D) White blood
in each group. Values are given as the mean ± SEM.
Figure 4 Lung histology in HAPE mice. Light micrograph of hematoxylin and eosin stained paraffin embedded section AQP5 −/− and
wildtype vs. controls. The alveolar edema was shown by arrows. Magnification × 200 and × 400.
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nificant difference between them (p > 0.05) (Figure 5).
Discussion
Previous results believed that the high-altitude pulmo-
nary edema (HAPE) is a lethal, non-cardiogenic form ofFigure 5 Alveolar-capillary permeability by Evan’s blue
method. **p < 0.01 for the HE groups between AQP5 −/− and
wildtype vs. HR and controls; &&p < 0.01 for the HR AQP5 −/− vs.
HE and controls; &p < 0.05 for the HR wildtype vs. HE and controls.
n = 3 in each group. Values are given as the mean ± SEM.pulmonary edema that afflicts susceptible individuals
above 3000 m sea level. But a few of people have better
tolerant to hypoxia and the development of HAPE
[15,32]. According to the previous results, the hypoxia
and exercise are considered as the main reasons of
HAPE. Therefore, we established mice models of HAPE-
like symptoms to investigate the mechanisms of HAPE
under the exertion and hypoxic conditions. While the
mice walked on treadmill and exposed on hypobaric
hypoxia chamber which contribute to the increasing
wet-to-dry weight ratio, lung total protein, albumin and
blood cell counts in BAL (Figures 2 and 3). These data
suggested that the HE group mice developed typical
HAPE-like symptoms as determined by physiological
analysis but the conditions need to be further optimized.
Indeed, although BAL total protein and albumin con-
centration were obviously increased in mice exposed to
hypoxia, the increase was higher when mice were simul-
taneously exposed to both hypoxia and exercise (Figure 3),
suggesting an exacerbating of endothelial permeability
[10,33]. In addition, microscopy analysis explored that
hypoxia alone induces slight alveolar epithelium and capil-
lary endothelium disruption and swelling, while combined
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swelling and disruption. In the study, the alveolar-capillary
permeability is measured to the integrity of alveolar-
capillary barrier by Evan’s blue method [24,27]. Moreover,
in our study, HR mice, present the medium situation
symptoms that from normal to HAPE development,
which could correspond to subclinical HAPE in human.
Indeed, the Evan’s blue content, interstitial edema score,
the BAL albumin concentration the W/D ratio and the
BAL red blood cell content in lungs of HR group were sig-
nificantly higher compared with NR and HE groups. They
were consistent with a significant increase in the lung
wet-to-dry weight ratio and bronchoalveolar lavage in the
present study. These results suggested Evan’s blue method
could be detected the alveolar-capillary permeability for
HAPE. Previous results indicated that hypoxic pulmonary
vasoconstriction induced pulmonary hypertension in
development of HAPE [34]. In addition, the alveolar
fluid leaking maybe contribute to, at least in part, the
pathogenic mechanism of alveolar epithelium integrity
[7,35]. So, the Alveolar epithelium swelling, disruption
and alveolar flooding during hypoxia and exercise suggest
maintaining epithelium barrier is of vital importance to
the maintenance of alveolar-capillary integrity and normal
alveolar function during HAPE development.
Another factor that has been believed to play an im-
portant role in the pathogenesis of HAPE is inflamma-
tion [11]. Previous studies reported that AQP5 deletion
in salivary gland inhibits active fluid secretion in the
lumen of serous acini [36], which is responsible for the
majority of water transport across the apical membrane
of type I alveolar epithelial cells [37]. Since AQP5 bi-
directionally facilitates fluid transport, defining of the
AQP5 effects on lung edema formation and resolution
[25,38]. However, there is no direct evidence to prove that
the AQP5 maintained alveolar-capillary barrier integrity in
HAPE. Thus we compared the depletion of AQP5 mice
and wildtype mice in affects lung edema formation and
lung histology for HAPE. In this study, the alveolar-
capillary permeability, the lung wet-to-dry weight ratio
and rich protein in BAL were significantly increased in the
AQP5 −/− mice of HE group. And histologic evidence of
hemorrhagic pulmonary edema was distinctly shown in
HE groups. These results suggest that AQP5 may play, at
most in part, an important role in alveolar epithelial bar-
rier function in formation of lung edema involve fluid
transport for HAPE.
We addressed the question that AQP5 is located on
the alveolar epithelium and thus would not contribute to
interstitial compartments across the microvascular endo-
thelium [14]. Previous study show that secretions Surfac-
tant Protein-A (SP-A) are described to useful for the
diagnostics of pulmonary edema and it plays a signifi-
cant role on the human pulmonary disorders and lungdiseases [39]. Mechanistically, it is understandable why
AQP5 should not facilitate the alveolar-capillary integ-
rity. Further, it is believed that the accumulation of al-
veolar edema involves transient breakdown the integrity
of the alveolar-capillary barrier, permitting the entry of
solutes and protein. Therefore, bulk movement of fluid
through rifts in the alveolar barrier would not be expected
to involve in AQP5. However, our data do not rule out
the possibility that AQP5 is involved in other HAPE
pathophysilology such as resolution of lung edema [40],
gas exchange, alveolar epithelial cell migration and volume
regulation [17]. An important function of the epithelium
is the active clearance of fluid from the alveolar alveolar-
spaces. Alveolar fluid absorption contributes to the reso-
lution of pulmonary edema in HAPE. Water transports is
driven by osmotic gradients created by salt transport by a
presumed near-isomolar transport mechanism in which
the osmotic gradient drive water movement across the
highly alveolar-capillary permeability [41]. It is not clear
how an apical membrane water-transporting protein might
be involved in these processes. Further studies are needed
to elucidate these questions.
Conclusions
In summary, our model of exercising mice exposed to hyp-
oxia is able to induce HAPE-like features. We demonstrated
that the high permeability type of HAPE by Evan’s blue
method. Maintaining alveolar-epithelium barrier integrity did
not appear to be crucial in AQP5 deletion mice, the results
indicate that AQP5 plays, at most a part, role in pulmonary
edema formation induced by high altitude simulation. The
correlation between elevated albumin concentration in the
BAL, higher W/D ratio and increased endothelium swelling
suggested that alveolocapillary barrier stress failure and the
AQP5 played an important role in the development of
HAPE. Future research is needed to study the potential func-
tion of other aquaporins for HAPE.
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